MPO and depressive symptom measurement: Another study found that the impact of acute COVID-19 on affective symptoms in long-COVID (anxiety and depression) were partially mediated by reduced GPx activity, lower zinc levels, and increased myeloperoxidase and nitric oxide production [87].